| dbo:abstract |
Helmy Eltoukhy is an American scientist, entrepreneur, and investor best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine’s inaugural 50 Most Influential People in Healthcare (2018) and Fortune’s 40 under 40 (2017). Acquired by Illumina in 2008, Avantome was founded to develop and commercialize semiconductor-based DNA sequencing, during the race for the $1,000 genome. Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. (en) |
| dbo:academicDiscipline |
dbr:Electrical_engineering dbr:Genomics |
| dbo:almaMater |
dbr:Stanford_University |
| dbo:doctoralAdvisor |
dbr:Abbas_El_Gamal |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Helmy_Eltoukhy.jpg?width=300 |
| dbo:wikiPageExternalLink |
https://www.cnbc.com/video/2019/06/03/new-blood-testing-technology-may-be-able-to-detect-cancer.html |
| dbo:wikiPageID |
62193315 (xsd:integer) |
| dbo:wikiPageLength |
33299 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1123267868 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Cancer dbr:Bellarmine_College_Preparatory dbr:Biopsy dbr:Integrated_circuit dbr:Investor dbr:$1,000_genome dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbr:Colorectal_cancer dbr:Master_of_Science dbr:Electrical_engineering dbr:Entrepreneur dbr:Genomics dbr:Third-generation_sequencing dbr:Signal_processing dbr:Stanford_University dbr:Startup_company dbr:Clinical_Cancer_Research dbr:Clinical_trial dbr:Massive_parallel_sequencing dbr:Mutational_signatures dbr:Bachelor_of_Science dbc:21st-century_American_biologists dbc:Cancer_researchers dbc:Stanford_University_alumni dbr:Time_(magazine) dbr:Doctor_of_Philosophy dbr:Liquid_biopsy dbr:Abbas_El_Gamal dbr:DNA_sequencing dbr:Food_and_Drug_Administration dbr:Fortune_(magazine) dbr:Fast_track_(FDA) dbr:Epigenetic dbr:Softbank_Group dbr:Artificial_intelligence dbr:AstraZeneca dbc:American_technology_company_founders dbc:Stanford_University_School_of_Engineering_alumni dbc:American_health_care_businesspeople dbc:Businesspeople_in_the_health_care_industry dbr:Big_data dbr:Thesis dbr:Image_sensors dbr:Doctorate dbr:CMOS dbr:Circulating_tumor_DNA dbr:Human_Genome_Project dbr:IPO dbr:Illumina,_Inc. dbr:Institute_of_Electrical_and_Electronics_Engineers dbr:Minimally_invasive_procedure dbr:Nasdaq dbr:New_York_Stock_Exchange dbr:Oncologist dbr:Cancer_research dbr:Cancer_staging dbr:World_Economic_Forum dbr:Scientist dbr:Venture_capital dbr:National_Human_Genome_Research_Institute dbr:Postdoctoral_researcher dbr:Companion_diagnostic dbr:Molecular_diagnostics dbr:Mostafa_Ronaghi dbr:Personalized_medicine dbr:PLOS_One dbr:CtDNA dbr:Semiconductor_sequencing |
| dbp:almaMater |
dbr:Stanford_University Stanford Genome Technology Center (en) |
| dbp:doctoralAdvisor |
dbr:Abbas_El_Gamal |
| dbp:fields |
dbr:Electrical_engineering dbr:Genomics |
| dbp:knownFor |
Co-Founder & CEO, Avantome (en) Co-Founder & CEO, Guardant Health (en) |
| dbp:name |
Helmy Eltoukhy (en) |
| dbp:spouse |
Carson Eltoukhy (en) |
| dbp:thesisTitle |
An integrated system for de novo DNA sequencing (en) |
| dbp:wikiPageUsesTemplate |
dbt:Reflist dbt:Short_description dbt:Small dbt:PMID dbt:Infobox_scientist |
| dcterms:subject |
dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbc:21st-century_American_biologists dbc:Cancer_researchers dbc:Stanford_University_alumni dbc:American_technology_company_founders dbc:Stanford_University_School_of_Engineering_alumni dbc:American_health_care_businesspeople dbc:Businesspeople_in_the_health_care_industry |
| rdf:type |
owl:Thing foaf:Person dbo:Person dul:NaturalPerson wikidata:Q19088 wikidata:Q215627 wikidata:Q5 wikidata:Q729 dbo:Animal dbo:Eukaryote dbo:Scientist dbo:Species schema:Person wikidata:Q901 |
| rdfs:comment |
Helmy Eltoukhy is an American scientist, entrepreneur, and investor best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine’s inaugural 50 Most Influential People in Healthcare (2018) and Fortune’s 40 under 40 (2017). Acquired by Illumina in 2008, Avantome was founded to develop and commercialize semiconductor-based DNA sequencing, during the race for the $1,000 genome. Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. (en) |
| rdfs:label |
Helmy Eltoukhy (en) |
| owl:sameAs |
wikidata:Helmy Eltoukhy https://global.dbpedia.org/id/BY7cv |
| prov:wasDerivedFrom |
wikipedia-en:Helmy_Eltoukhy?oldid=1123267868&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Helmy_Eltoukhy.jpg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Helmy_Eltoukhy |
| foaf:name |
Helmy Eltoukhy (en) |
| is dbo:institution of |
dbr:Richard_B._Lanman |
| is dbo:wikiPageRedirects of |
dbr:Guardant_Health |
| is dbo:wikiPageWikiLink of |
dbr:List_of_entrepreneurs dbr:Bellarmine_College_Preparatory dbr:Richard_B._Lanman dbr:Maurice_Stroun dbr:List_of_Stanford_University_people dbr:Illumina,_Inc. dbr:Mostafa_Ronaghi dbr:List_of_Bellarmine_College_Prep_alumni dbr:Guardant_Health |
| is dbp:name of |
dbr:List_of_Bellarmine_College_Prep_alumni |
| is dbp:workInstitutions of |
dbr:Richard_B._Lanman |
| is foaf:primaryTopic of |
wikipedia-en:Helmy_Eltoukhy |
